ORAL CAVITY CANCER
Clinical trials for ORAL CAVITY CANCER explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY CANCER trials appear
Sign up with your email to follow new studies for ORAL CAVITY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 people with advanced head and neck cancer that had come back or spread. Participants were grouped based on whether they had tried these drugs before. The goal was to see if the combination could shri…
Matched conditions: ORAL CAVITY CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 17, 2026 04:01 UTC
-
Immunotherapy combo shows promise in head and neck cancer trial
Disease control CompletedThis early-phase trial tested adding the immunotherapy drug pembrolizumab to standard chemo-radiation for people with advanced head and neck cancer. 59 participants received the combination to see if it was safe and how many had their tumors disappear. The goal was to improve tre…
Matched conditions: ORAL CAVITY CANCER
Phase: PHASE1 • Sponsor: Sanford Health • Aim: Disease control
Last updated May 15, 2026 11:57 UTC